MILIO, Glauco
 Distribuzione geografica
Continente #
NA - Nord America 2.503
EU - Europa 1.628
AS - Asia 583
SA - Sud America 15
AF - Africa 12
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.746
Nazione #
US - Stati Uniti d'America 2.498
IT - Italia 494
UA - Ucraina 360
CN - Cina 327
FI - Finlandia 261
SG - Singapore 181
DE - Germania 118
IE - Irlanda 110
GB - Regno Unito 77
SE - Svezia 50
FR - Francia 43
RU - Federazione Russa 36
BE - Belgio 26
KR - Corea 19
TR - Turchia 18
IN - India 16
RO - Romania 14
CH - Svizzera 13
BR - Brasile 12
CI - Costa d'Avorio 12
NL - Olanda 11
IR - Iran 9
AT - Austria 4
HK - Hong Kong 4
AU - Australia 3
CA - Canada 3
GR - Grecia 3
LB - Libano 3
BO - Bolivia 2
ES - Italia 2
HR - Croazia 2
UZ - Uzbekistan 2
AL - Albania 1
AR - Argentina 1
CR - Costa Rica 1
EU - Europa 1
GE - Georgia 1
IL - Israele 1
JP - Giappone 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
Totale 4.746
Città #
Chandler 279
Fairfield 222
Jacksonville 198
Ashburn 196
Ann Arbor 170
Woodbridge 163
Wilmington 141
Singapore 129
Houston 113
Dublin 110
Medford 85
Seattle 77
Nanjing 74
Cambridge 71
Des Moines 70
Palermo 54
Princeton 53
Tulsa 50
Boardman 34
Dearborn 29
Brussels 25
Jinan 25
San Diego 24
Shenyang 24
Altamura 21
Hebei 21
Nanchang 20
San Mateo 20
Changsha 19
Jiaxing 19
New York 19
Beijing 17
Izmir 17
Milan 17
Rome 16
Lawrence 13
Seongnam 13
Tianjin 13
Abidjan 12
Ningbo 11
Zhengzhou 11
Pune 10
Verona 10
Ludwigshafen am Rhein 9
Santa Clara 9
Auburn Hills 8
Catania 8
Columbus 8
Munich 8
Taizhou 8
Bari 7
Lanzhou 7
Tehran 7
Falls Church 6
Guangzhou 6
Haikou 6
Kunming 6
Affoltern am Albis 5
Bremen 5
London 5
Los Angeles 5
Mykolayiv 5
Redwood City 5
Reseda 5
Saint Petersburg 5
Shanghai 5
Torino 5
Enna 4
Hangzhou 4
Kumar 4
Medolago 4
Mirano 4
Naples 4
Orange 4
Taiyuan 4
Venice 4
Central District 3
Fano 3
Fuzhou 3
Hefei 3
Melbourne 3
Monza 3
Norwalk 3
Redmond 3
Seoul 3
Ancona 2
Atlanta 2
Bolzano 2
Catanzaro 2
Fermo 2
Florence 2
Galatina 2
Genoa 2
Genova 2
Hanover 2
Kiev 2
Kilburn 2
La Paz 2
Lleida 2
Mediglia 2
Totale 2.961
Nome #
Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol 182
Pharmacological Treatment of Patients with Chronic Critical Limb Ischemia: L-Propionyl-Carnitine Enhances the Short-Term Effects of PGE-1 157
Ischemia critica cronica e vasculopatia ischemica polidistrettuale 151
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: The Duration of Anticoagulation based on Compression Ultrasonography (DACUS) study 145
Changes of arterial hemodynamics in patients with type 2 diabetes mellitus or impaired glucose tolerance 144
Modello di percorso diagnostico e terapeutico per l'arteriopatia obliterante periferica 142
Critical limb ischaemia: definition and natural hystory 138
Asymptomatic Carotid Lesions and Aging: Role of Hypertension and Other Traditional and Emerging Risk Factors 138
Asymptomatic carotid lesions and aging: role of hypertension and other traditional and emerging risk factors 134
Antiplatelet treatment in ischemic stroke treatment. 128
Subclavean stenosis/occlusion in patients with subclavean steal and previous by pass of internal mammary interventricular anterior artery: medical or surgery treatment? 127
Superficial venous thrombosis: Prevalence of common genetic risk factors and their role on spreading to deep veins 118
Response to letter by Drs. Mohammed Abbas, Maria Sessa, and Francesco Corea 106
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis 103
Modello di percorso diagnostico e terapeutico per la trombosi venosa superficiale 103
null 100
Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial 96
Sodium thiosulfate not always resolves calciphylaxis: an ambiguous response 96
Stress ossidativo in pazienti con sclerodermia: effetti dell’iloprost. 93
Immunohistochemical expression of iNOS and metalloproteinases MMP2 and MMP9 in abdominal inflammatory aortic Aneurysms 92
Effetti dell’iloprost sulla disfunzione leucocitaria nella sclerodermia. 89
La terapia metabolica nel trattamento dell'ischemia critica cronica degli arti inferiori: la L-propionilcarnetina potenzia gli effetti della PGE-1 89
Moderno approccio alla trombosi venosa superficiale 86
Absence of residual vein thrombosis after an episode of idiopatic deep vein thrombosis: short-term anticoagulation is safe. The extended DACUS Study 84
Effetti emoreologici del trattamento con iloprost in pazienti con fenomeno di Raynaud secondario a sclerodermia. 83
Absence of residual vein thrombosis after an episode of idiopatic deep vein thrombosis: short-term anticoagulation is safe. The extended DACUS study. 83
MTHFR allele 677T band risk of abdominal aortic aneurysm 82
Aspetti fisiopatologici dell'ulcera venosa 81
THE EFFECTS OF PROSTAGLANDIN E-1 IN PATIENTS WITH INTERMITTENT CLAUDICATION 81
Residual vein thrombosis assessment establishes the otpimal duration of oral anticoagulants in patients with idiopathic or provoked deep vein thrombosis 80
Calf vein thrombosis: optimal duration of treatment 80
Residual vein thrombosis estabilishes the optimal duration of oral anticoagulants for the treatment od DVT 71
Superficial venous thrombosis: role of genetic risk factors on spreeding to deep veins 70
Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial 68
Trombosi venosa superficiale ed estensione al circolo profondo: ruolo dei fattori di rischio genetici 68
Calf vein thrombosis: optimal duration of tretment 67
SUPERFICIAL VENOUS THROMBOSIS: ROLE OF GENETIC RISK FACTORS ON SPREADING TO DEEP VEINS 66
Comportamento della eNOS e dell'iNOS nella genesi e mantwnimento delle ulcere venose degli arti inferiori 65
Efficacy of the treatment with prostaglandin E-1 in venous ulcers of the lower limbs 63
Calf veins thrombosis: optimal duration of treatment 62
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis. a randomized, controlled trial 60
Peso dei fattori di rischio nell’evoluzione dell’aterosclerosi preclinica 60
Metabolic therapy in the treatment of chronic critical limbs ischemia: the L-propionyl-carnitine enhances the effects of PGE-1 59
Immunohistochemical expression of iNOS and eNOS in the venous ulcers related to chronic venous insufficiency (CVI). 59
Ischemia critica e connettiviti: presupposti fisiopatologici per un protocollo di trattamento 58
null 57
Trattamento delle manifestazioni vascolari nella Sclerosi Sistemica e qualità della vita: nuovo protocollo 57
Superficial venous thrombosis and spreading to deep veins: role of genetic risk factors for venous thromboembolism 57
The effects Prostaglandine E-1 in patients with intermittent claudication 56
The effects of Prostaglandin E-1in patients with intermittent claudication 56
TROMBOSI PROFONDA SUPERFICIALE ED ESTENSIONE AL CIRCOLO PROFONDO: RUOLO DEI FATTORI DI RISCHIO GENETICI 51
METABOLIC THERAPY IN THE TREATMENT OF CHRONIC CRITICAL LIMBS ISCHEMIA OF THE LOWER LIMBS. THE L-PROPIONYL-CARNITINE ENHANCES THE EFFECTS OF PGE-1 48
Rilievi emoreologici nella sclerosi sistemica. 47
Il trattamento domiciliare della TVP 42
NO and Chronic Venous Insufficiency (CVI): Immunohistochemical Evaluation of iNOS and eNOS Isofroms in the Venous Ulcers. Clinical and Therapeutical Possible Implications 25
Totale 4.803
Categoria #
all - tutte 16.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.220


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020613 0 0 0 0 0 115 109 43 101 42 127 76
2020/2021629 16 76 48 64 71 32 59 31 77 20 71 64
2021/2022539 18 139 5 35 20 7 27 23 65 68 20 112
2022/2023762 82 97 9 87 86 117 64 63 94 16 41 6
2023/2024301 14 48 17 31 21 79 33 7 1 7 5 38
2024/2025288 19 54 30 109 55 21 0 0 0 0 0 0
Totale 4.803